Holen Sie sich die Stockscreener-App
4.87
2.40%
-0.12
Handel nachbörslich:
5.08
0.21
+4.31%
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
Shareholders that lost money on Atara Biotherapeutics, - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Atara - GlobeNewswire
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-04-05 | ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ATRA | Press Release - Stockhouse
Atara Biotherapeutics, Inc. (ATRA) registers possible resale of 400K common shares tied to HCR warrant exercise - MSN
Securities Fraud Investigation Into Atara Biotherapeutics, Inc - natlawreview.com
ATRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit - Lelezard
ATRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - Sahm
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure ... - Black Hills Pioneer
ROSEN Counsel Encourages Atara Biotherapeutics Investors to Act - National Today
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Atara - GlobeNewswire
ATRA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire
ATRA Technical Analysis & Stock Price Forecast - Intellectia AI
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ATRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Atara Biotherapeutics, Inc. (ATRA) Registers Possible Resale of 400K Common Shares Tied to HCR Warrant Exercise - Yahoo Finance
Aug Sectors: Is Atara Biotherapeutics Inc being accumulated by smart moneyWeekly Profit Report & Smart Investment Allocation Tips - baoquankhu1.vn
Deadline Alert: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - The Norfolk Daily News
DEADLINE ALERT for LU, ATRA, and COTY: The Law Offices of - GlobeNewswire
ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain OfficersATRA - PR Newswire
ATRA Stock Price, Quote & Chart | ATARA BIOTHERAPEUTICS INC (NASDAQ:ATRA) - ChartMill
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Atara Biotherapeutics Faces Class Action Lawsuit - Intellectia AI
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors ... - Bluefield Daily Telegraph
Atara Biotherapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 22, 2026 to Discuss Your RightsATRA - marketscreener.com
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx - GlobeNewswire Inc.
2026-04-01 | ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ATRA | Press Release - Stockhouse
Did You Lose Money Investing in Atara Biotherapeutics, - GlobeNewswire
Pomerantz Law Firm Files Class Action Against Atara Biotherapeutics - National Today
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics Lawsuit - National Today
FinancialContentPomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers – ATRA - FinancialContent
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Atara - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Lead Plaintiff - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action - businesswire.com
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff Deadline in - GuruFocus
ATRA Shareholder Alert: May 22, 2026 Lead Plaintiff Deadline in Atara Biotherapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm - Morningstar
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Atara Biotherapeutic - natlawreview.com
Atara Biotherapeutics | 10-K: FY2025 Annual Report - Moomoo
Class Action Filed Against Atara Biotherapeutics, Inc. (ATRA) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
ATRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure ... - Black Hills Pioneer
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Bioth - GuruFocus
ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages Atara - GlobeNewswire
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
ATRA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Atara ... - Bluefield Daily Telegraph
ATRA Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
ATRA Class Action ReminderRobbins LLP Reminds Investors - GlobeNewswire
Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - ChartMill
[EFFECT] Atara Biotherapeutics, Inc. SEC Filing - stocktitan.net
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):